Live Breaking News & Updates on Lumiradx Investment|Page 7

Stay updated with breaking news from Lumiradx investment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System

Next-generation antigen test system built on more than eight years of research and backed by industry leading microfluidic expertsThe Amira System includes the Amira Analyzer, Amira SARS-CoV-2 ....

United Kingdom , City Of , Ron Zwanziger , Exchange Commission , Prnewswire Lumiradx Limited Nasdaq , Amira System , Amira Analyzer , Chief Executive Officer , Securities Litigation Reform Act , Annual Report ,

LumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete and LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete

LONDON, June 8, 2022 /PRNewswire/ LumiraDx Limited (Nasdaq: LMDX) today announced that it has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 ....

United Kingdom , City Of , Sanjay Malkani , Exchange Commission , Fast Lab Solutions , Lumiradx Fast Lab Solutions , Prnewswire Lumiradx Limited Nasdaq , Lumiradx Fast Lab , Lumiradx Platform , Securities Litigation Reform Act , Annual Report ,

LumiraDx (NASDAQ:LMDX) Stock Rating Upgraded by Zacks Investment Research

LumiraDx (NASDAQ:LMDX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “LumiraDx Limited is a point of care diagnostics company. Its testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, […] ....

United States , Raymond James , Penserra Capital Management , Healthcare Acquisition Corp , Goldman Sachs Group Inc , Zacks Investment Research , Lumiradx Company Profile Get Rating , Susquehanna International Group , Capital Management , Get Rating , Acquisition Corp , Sachs Group , International Group , Prescott General Partners , General Partners , Nasdaq Lmdx ,

LumiraDx Expands its Cardiovascular Testing Portfolio with CE Marking of its NT-proBNP Test and new Exclusion Claim for its D-Dimer Test

The LumiraDx NT-proBNP and the LumiraDx D-Dimer tests are currently the only quantitative direct fingerstick assays produced for each test. Run on the highly. ....

United Kingdom , Cle Gal , Ron Zwanziger , Exchange Commission , Emergency Department , Lumiradxd Dimer , Chief Executive Officer , Lumiradx Platform , Securities Litigation Reform Act , Annual Report , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , New Products Amp Services ,

LumiraDx HbA1c Test Achieves CE Mark, Addresses Growing Global Need for Diabetes Screening and Monitoring with its Next-Generation Point of Care Diagnostic Platform

Rapid microfluidic immunofluorescence assay intended for the monitoring of individuals with diabetes, and as an aid in screening and identifying patients who may be at risk for developing diabetesThe ....

United Kingdom , City Of , Ron Zwanziger , Colleen Mcmillen , Exchange Commission , Prnewswire Lumiradx Limited Nasdaq , Lumiradx Platform , Lumiradx Hba , Chief Executive Officer , Securities Litigation Reform Act , Annual Report ,